158 related articles for article (PubMed ID: 6219125)
1. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
Merrill JE
J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-induced natural killer.
Merrill JE; Myers LW; Ellison GW
J Neuroimmunol; 1983 Jun; 4(3):239-51. PubMed ID: 6189856
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
Hattori T; Hirata F; Hoffman T; Hizuta A; Herberman RB
J Immunol; 1983 Aug; 131(2):662-5. PubMed ID: 6223089
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
Fukui H; Overton WR; Herberman RB; Reynolds CW
J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
6. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
[TBL] [Abstract][Full Text] [Related]
7. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
Santoni A; Herberman RB; Holden HT
J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
[TBL] [Abstract][Full Text] [Related]
8. Divergent effects of methylxanthines and adenylate cyclase agonists on monocyte cytotoxicity and cyclic AMP levels.
Herlin T; Kragballe K
Eur J Clin Invest; 1982 Aug; 12(4):293-9. PubMed ID: 6183123
[TBL] [Abstract][Full Text] [Related]
9. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
10. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of cytokines on natural killer and antibody dependent cellular cytotoxicity directed to squamous cell carcinoma targets by lymphocytes from oral cancer patients.
Desai SA; Maniar HS; Rao RS; Fakih AR; Gangal SG
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):69-73. PubMed ID: 8180580
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
13. Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity.
Shao-Hsien C; Lang I; Gunn H; Lydyard P
Transplantation; 1983 Feb; 35(2):127-9. PubMed ID: 6829073
[TBL] [Abstract][Full Text] [Related]
14. Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patients.
Moody DJ; Fahey JL; Durkos-Smith D; Ellison GW; Myers LW
J Immunopharmacol; 1986; 8(2):259-69. PubMed ID: 2941487
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
J Reprod Immunol; 1996 Aug; 31(1-2):125-41. PubMed ID: 8887127
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
Sung MW; Johnson JT; Van Dongen G; Whiteside TL
Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
18. Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro.
Ge S; Chu M; Choi J; Louie S; Vo A; Jordan SC; Toyoda M
Transplantation; 2020 Aug; 104(8):1574-1579. PubMed ID: 32732834
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
J Clin Immunol; 1984 Jul; 4(4):312-8. PubMed ID: 6378956
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
